Title
Effect of Cranberry and Agaves Extract on Microbiota and Intestinal Health
Prebiotic Supplementation and Metabolic Endotoxemia and Modulation of the Gut Microbiota: Double-blind and Randomized Parallel Clinical Study of the Efficacy and Synergistical Effect of Cranberry Polyphenols and Inulin From Agaves
Phase
N/ALead Sponsor
Laval UniversityStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Endotoxemia Metabolic Syndrome Glucose Metabolism Disorders Insulin ResistanceStudy Participants
122The growing prevalence of obesity and type 2 diabetes (T2D) is a major public health problem. Recent studies have clearly established that the gut microbiota plays a key role in the investigator's propensity to develop obesity and associated metabolic health disorders. The gut microbiota compositions plays a decisive role in glucose metabolism and the chronic inflammatory state associated with insulin resistance. Consuming prebiotic rich diet, including polyphenol and inulin rich food could help modulate favorably the gut microbiota which could lead to a reduction of endotoxemia and beneficial metabolic health effects.
It is now recognized that overweight individuals have altered microbiota which could lead to intestinal barrier defects and chronic inflammation disorders. Polyphenols such as Proanthocyanidins may modulate the gut microbiota thereby providing beneficial effects on metabolic health. Inulin is a well known prebiotic that could stimulate growth of favorable bacteria in the gut.
The overall goal is to determine the efficacy and synergy of a supplement of polyphenols from cranberry extract with or without a supplement of inulin from agaves to reduce chronic inflammation and endotoxemia and to improve glucose metabolism and insulin sensitivity by modulating microbiota of overweight human subjects with metabolic syndrome symptoms.
Cranberry extract (2 capsules) + Agaves powder (1 single-dose packet)
Cranberry extract (2 capsules) + Placebo powder (1 single-dose packet)
Placebo (2 capsules) + Agaves powder (1 single-dose packet)
Placebo (2 capsules) + Placebo powder (1 single-dose packet)
Inclusion Criteria: overweight (BMI 25-39.9 kg/m2) or waist circumference ≥ 80 cm (women) and ≥94 cm (men) fasting insulin over 60 pmol/L or fasting glucose 5.6 - 6.9 mmol/L at least one of the following criteria: Tg ≥ 1.7 mmol/L; blood pressure ≥ 130/85 mmHg; HDL < 0,9 mmol/L; hsCRP 1-10 mg/L non-smoking eating fruits and vegetables less then 5 portions/day Exclusion Criteria: chronic disease taking drugs or natural health products that could affect glucose or lipid metabolism taking anti-inflammatory, antiacids taking pre or probiotics inflammatory bowel disease antibiotics in the past 3 months allergy or intolerance to cranberries or agaves Major surgery in the past 3 months